The Study of Sarcopenia and Aging Biomarkers by the Metabolomics

• Conditions: Sarcopenia; Aging

• Registration Number: NCT03121326
• Lead Sponsor: Chang Gung Memorial Hospital

Brief Summary

With the rapid growth of the global elderly population, the studies of the biomarkers of the sarcopenia and aging are under investigation in different ways. The investigators use Metabolomics to explore the biomarkers of the sarcopenia and aging of the senior adults.

Detailed Description

Metabolomics is the emerging platform technology to address the complexity of a living system. In translational research, metabolomics approaches may enable the detection of multiple disease risk factors and interactions, disease progression, and response of patients to a particular therapy with or without side effects. Metabolomics may provide comprehensive information and improve diagnosis and prognosis which are particularly promising in human complex degenerative diseases. The investigators use Metabolomics to explore the biomarkers of the sarcopenia and aging of the senior adults.

Study Timeline

• Status Verified: 2017-03
• Study Start: 2017-03-06
• Primary Completion: 2017-03-15
• Study First Submitted: 2017-04-17
• Study First Submitted QC: 2017-04-19
• Study First Posted: 2017-04-20
• Last Update Submitted: 2017-05-17
• Last Update Posted: 2017-05-19
• Study Completion: 2017-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 650

Inclusion Criteria

• residents of the Chang Gung Health and Culture Village
• mostly independent and do not require nursing assistance
• capable of managing their daily living activities
• aged ≧ 60

Exclusion Criteria

• None.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The biomarkers of the sarcopenia and aging in senior adults.	one year	Metabolomics to explore the biomarkers of the sarcopenia and aging.

Trial Locations

Locations (1)

Chang Gung University; 🇨🇳 Taoyuan, Taiwan